Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

In-Vitro Toxicology Testing Market - Global Forecast 2026-2032 | $31.73 Billion Opportunity by 2032 as AI, Organ-on-Chip, 3D Models, and Regulatory Support Accelerate Non-Animal Testing

globenewswire.com
ABT Abbott Laboratories is listed as a company in the competitive landscape of the in-vitro toxicology testing market, but no specific details about its performance or outlook in this segment are provided. BDX Becton, Dickinson and Company is listed among companies in the in-vitro toxicology testing market. The article does not offer specific sentiment or performance analysis for the company. BRKR Bio-Rad Laboratories, Inc. is identified as a player in the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company. CRL Charles River Laboratories International, Inc. is mentioned as a company in the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company. IQV IQVIA Holdings Inc. is listed as a company in the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company. LH Laboratory Corporation of America Holdings is listed as a company within the in-vitro toxicology testing market's competitive landscape. The article does not provide specific sentiment or performance details. MRK Merck KGaA is listed as a company in the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company. QGEN Qiagen N.V. is mentioned as a company within the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company. TMO Thermo Fisher Scientific Inc. is listed as a company in the in-vitro toxicology testing market. The article does not provide specific sentiment or performance details for the company.

In-Vitro Toxicology Testing Market - Global Forecast 2026-2032 | $31.73 Billion Opportunity by 2032 as AI, Organ-on-Chip, 3D Models, and Regulatory Support Accelerate Non-Animal Testing Dublin, Nov. 20, 2026 (GLOBE NEWSWIRE) -- "In-Vitro Toxicology Testing Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report examines the global in-vitro toxicology testing market, projected to grow from USD 16.21 billion in 2026 to USD 31.73 billion by 2032 at a CAGR of 11.52%. It evaluates the technologies, regulatory developments, applications, and regional trends shaping demand across pharmaceutical, biotechnology, chemical, cosmetic, food ingredient, and medical device industries.

Market Overview and Growth Drivers

In-vitro toxicology testing is evolving from a supporting research tool into a core platform for safety assessment and product development. Validated assays, human-relevant cell models, 3D cell cultures, organ-on-chip systems, high-throughput screening, and computational toxicology are reducing reliance on animal testing while strengthening early safety predictions.

Regulatory momentum is accelerating adoption. The FDA Modernization Act 2.0 removed the statutory requirement for animal testing before human drug trials in the United States. In Europe, the cosmetics animal-testing ban, Directive 2010/63/EU, and continued support for the 3Rs reinforce demand for alternative methods. OECD guidelines covering skin and eye effects, phototoxicity, genotoxicity, and endocrine activity provide a recognized framework for wider acceptance.

Transformative Technology Shifts

Conventional monolayer assays remain important for cytotoxicity and genotoxicity screening, but demand is increasing for models that more accurately replicate human tissue architecture, metabolism, and exposure dynamics.

Technology comparisons and adoption signals support strategic planning by helping decision-makers prioritize platforms with the strongest scientific, regulatory, and commercial potential.

Artificial Intelligence and Advanced Analytics

Artificial intelligence is expanding the value of toxicology testing by connecting assay results with chemical structures, omics datasets, adverse outcome pathways, and exposure information. Key applications include image-based toxicity scoring, quantitative structure-activity relationship modeling, dose-response prediction, high-content screening, and compound prioritization.

AI complements rather than replaces laboratory science. Regulatory relevance depends on traceable data, validated models, reproducible algorithms, bias controls, explainability, and clearly defined applicability domains. These insights allow organizations to assess technology partnerships and mitigate implementation risks before committing resources.

End-User and Application Insights

Competitive differentiation increasingly depends on biological relevance, reproducibility, endpoint sensitivity, regulatory documentation, and scalable automation.

Regional and Country Insights

Country-level analysis provides a practical foundation for market-entry planning, partnership selection, and geographic opportunity assessment.

Strategic Priorities for Industry Leaders

Key Takeaways from This Report

Key Attributes

Key Topics Covered

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. In-Vitro Toxicology Testing Market, by Service Type

7.1. Introduction

7.2. Biochemical Assays

7.3. Cell Culture Assays

7.3.1. Cell Line Assays

7.3.2. Primary Cell Assays

7.4. Computational Models

8. In-Vitro Toxicology Testing Market, by Technology

8.1. Introduction

8.2. High Throughput Screening

8.2.1. Assay Based

8.2.2. Imaging Based

8.3. Microfluidics

8.4. Organ On Chip

8.5. Three Dimensional Culture

9. In-Vitro Toxicology Testing Market, by Application

9.1. Introduction

9.2. Cosmetics Testing

9.2.1. Ocular Irritation

9.2.2. Skin Irritation

9.3. Drug Discovery

9.3.1. Lead Optimization

9.3.2. Target Validation

9.4. Safety Assessment

9.4.1. Carcinogenicity

9.4.2. Cytotoxicity

9.4.3. Genotoxicity

10. In-Vitro Toxicology Testing Market, by End User

10.1. Introduction

10.2. Academic And Research Institutes

10.3. Contract Research Organizations

10.4. Pharma And Biotech

11. In-Vitro Toxicology Testing Market, by Region

11.1. Introduction

11.2. Asia-Pacific

11.3. North America

11.4. Latin America

11.5. Europe

11.6. Middle East

11.7. Africa

12. In-Vitro Toxicology Testing Market, by Group

12.1. Introduction

12.2. ASEAN

12.3. GCC

12.4. European Union

12.5. BRICS

12.6. G7

12.7. NATO

13. In-Vitro Toxicology Testing Market, by Country

13.1. Introduction

13.2. United States

13.3. Canada

13.4. Mexico

13.5. Brazil

13.6. United Kingdom

13.7. Germany

13.8. France

13.9. Russia

13.10. Italy

13.11. Spain

13.12. China

13.13. India

13.14. Japan

13.15. Australia

13.16. South Korea

14. Competitive Landscape

14.1. Market Share Analysis, 2025

14.2. Market Concentration Analysis, 2025

14.2.1. Concentration Ratio (CR)

14.2.2. Herfindahl Hirschman Index (HHI)

14.3. Recent Developments & Impact Analysis, 2025

14.4. Product Portfolio Analysis, 2025

14.5. Benchmarking Analysis, 2025

15. Company Profiles

15.1. Abbott Laboratories

15.2. Agilent Technologies, Inc.

15.3. Becton, Dickinson and Company

15.4. Bio-Rad Laboratories, Inc.

15.5. Bio-Techne Corporation

15.6. BioIVT LLC

15.7. Charles River Laboratories International, Inc.

15.8. Creative Bioarray

15.9. ERBC Group

15.10. Eurofins Scientific SE

15.11. Evotec SE

15.12. F. Hoffmann-La Roche AG

15.13. Gentronix Limited

15.14. HD Biosciences Co., Ltd.

15.15. INDIGO Biosciences, Inc.

15.16. Inotiv, Inc.

15.17. InSphero AG

15.18. Intertek Group PLC

15.19. Laboratory Corporation of America Holdings

15.20. LAUS GmbH

15.21. LGC Limited

15.22. Merck KGaA

15.23. Microbac Laboratories Inc.

15.24. Oroxcell

15.25. Promega Corporation

15.26. Qiagen N.V.

15.27. SGS SA

15.28. Thermo Fisher Scientific Inc.

15.29. Toxys, Inc.

15.30. Vimta Labs Ltd.

15.31. WuXi AppTec

16. Key Experts

List of Figures [19]

List of Tables [334]

For more information about this report visit https://www.researchandmarkets.com/r/5qyld1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.